Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

An Overview of CJC-1295 & Ipamorelin & GHRP-2 Blend

An Overview of CJC-1295 & Ipamorelin & GHRP-2 Blend by Dr. Usman | Jun 3, 2022 | Research CJC-1295 Peptide The growth hormone-releasing hormone (GHRH) is believed to be a natural regulator of somatotropin’s growth hormone. The replication of this hormone or it

By Recovery & Performance Peptides Editorial Team

An Overview of CJC-1295 & Ipamorelin & GHRP-2 Blend

by Dr. Usman | Jun 3, 2022 | Research

CJC-1295 Peptide

The growth hormone-releasing hormone (GHRH) is believed to be a natural regulator of somatotropin’s growth hormone. The replication of this hormone or its hypothetical derivatives has been a long-sought-after goal of research. This goal is speculated to improve cases of growth hormone deficiencies.

CJC-1295 peptide is a maleimido derivative of the first 29 amino acid sequences of the GHRH. A notable speculation about CJC-1295, which might distinguish it from other such derivatives, is that being a small molecular weight compound, it is considered to be more soluble and easier to produce on a large scale while potentially performing every necessary function GHRH might do.

CJC-1295 on Growth Hormone Release: The speculated impact of CJC-1295 exposure on growth hormone release is believed to be very different from that of other growth hormone secretagogues in two distinct ways. Firstly, it is speculated that CJC-1295 might expedite the increase in circulating growth hormone levels rapidly. Research suggests that a single introduction of CJC-1295 might bring up growth hormone (GH) levels to almost 2-9 times the normal within two hours in mice models of growth hormone deficiency. CJC-1295 is speculated to rapidly support the natural peaks and valleys of GH concentration that fit into the natural circadian rhythm.

Secondly, owing to its speculated mode of action, the CJC-1295 peptide is believed to cause the growth hormone levels to reach their physiologic maximum, but at the same time, it might keep the process regulated. This implies that the peptide might never let the levels reach a limit so high that it would start producing unintended physiological consequences.

Ipamorelin Peptide

Ipamorelin is believed to be a selective ghrelin receptor agonist with a speculated strong affinity for binding to ghrelin receptors. It is suggested to be one of the most particular growth hormone secretagogues. It is also believed to have varied actions on other vital hormones. These might include thyroid-stimulating hormone, cortisol, luteinizing hormone, prolactin, ACTH, and follicle-stimulating hormone.

GHRP-2 Peptide

GHRP-2 or Pralmorelin is believed to be a growth hormone secretagogue, i.e., it is speculated to act on the pituitary gland, potentially mimicking the action of GHRH and causing the release of growth hormone. It was one of the first growth hormone secretagogues introduced as a test peptide. GHRP-2 is speculated to bind to ghrelin receptors in the gastrointestinal tract and may potentially regulate many vital processes. Current speculative research tests its effects on sleep cycle, muscle cell growth, appetite regulation, and immune function modulation.

Dr. Usman

Dr. Usman (BSc, MBBS, MaRCP) completed his studies in medicine at the Royal College of Physicians, London. He is an avid researcher with more than 30 publications in internationally recognized peer-reviewed journals. Dr. Usman has worked as a researcher and a medical consultant for reputable pharmaceutical companies such as Johnson & Johnson and Sanofi.

Latest Post

BPC157: Molecular Characterization, Pleiotropic Signaling Mechanisms, and Preclinical Research

Copper Peptides: Molecular Characterization, Mechanistic Biology, and Emerging Research

Modified GRF 1-29 and GHRP-2 Peptide Blend: Receptor Pharmacology, Somatotroph Signaling, and Neuroendocrine Research

Fragment 176-191, Modified GRF 1-29, and Ipamorelin Blend: Adipose Metabolism, GH Axis Modulation, and Receptor Signaling Research

PNC-27: Structural Characterization, HDM-2-Dependent Membrane Targeting, and Selective Tumor Cell Necrosis

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

PROCEDURE

How to Properly Handle and Utilize CJC 1295 / Ipamorelin for Research

To ensure the integrity of your study, proper handling of peptides CJC 1295 and Ipamorelin is crucial. These compounds are delivered in a lyophilized (freeze-dried) state for maximum stability. The first step is reconstitution, which must be done carefully using a sterile solvent like our lab-grade Bacteriostatic Water. This ensures the peptide is properly dissolved without contamination. Once reconstituted, the solution should be refrigerated to maintain its potency for the duration of your research protocol. Accurate dosing and sterile techniques are non-negotiable for achieving valid, reproducible results in any laboratory setting. At Real Peptides, we provide the foundational materials you need to conduct your work with confidence, knowing you're starting with the highest possible purity. Begin your next project with compounds you can trust by exploring our complete peptide shop. Find the Right Peptide Tools for Your Lab
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

CJC-1295 & Ipamorelin & GHRP-2 Blend Research Into Growth Hormone Secretion

by Dr. Usman | Dec 3, 2024 | Research CJC-1295 belongs to a class of molecules referred to as growth hormone-releasing hormone (GHRH) agonists.[1] It is made of the first 29 amino acids of the native GHRH hormone, representing the shortest functional sequence of GHRH. Further, CJC-1295 appears to have several modifications, including the replacement of four of the original amino acids in the GHRH 1-29 sequence, as well as the attachment of a rug affinity complex (DAC) component that may bind to plasma proteins. More specifically, the DAC component in CJC-1295 refers to the attachment of N-epsilon-3-maleimidopropionamide derivative at the C terminus. These modifications are posited to support the stability of the molecule and prolong its half-life. Ipamorelin, also referred to as NNC 26-0161, is a pentapeptide with the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2.[2] This molecule belongs to the family of growth hormone-releasing peptides (GHRPs), which were initially derived from the structure of endogenously occurring pentapeptides called metenkephalins. Ipamorelin appears to be highly selective towards triggering the release of growth hormone from the pituitary gland cells. GHRP-2 (growth hormone-releasing peptide-2) appears to belong to the GHRP class as well.[3] It is a hexapeptide developed from the structure of met-enkephalins. Yet, GHRP-2 appears to be less selective in its actions compared to Ipamorelin. Contents: Mechanisms of Action CJC-1295 & Ipamorelin & GHRP-2 Blend Synergy References Featured Product

RESEARCH

CJC 1295 Ipamorelin Oakland | Research Peptides Source

For pioneering researchers in Oakland, sourcing high-purity peptides is paramount. The synergistic potential of peptides CJC 1295 and Ipamorelin offers a powerful tool for studies on growth hormone secretagogues. Real Peptides provides the quality and reliability your lab demands for breakthrough results in 2026.

POTENTIAL BENEFITS

What Are the Benefits of CJC-1295 / Ipamorelin / GHRP-2?

By targeting multiple GH release pathways, this peptide combination may offer enhanced wellness support, including:
05

Product & matchup locker

Linked catalog and comparison files.

Comparison

Comparison: GH Secretagogues vs. Direct T-Boosters

Let’s lay it out in a simple table to make the distinction crystal clear. Mechanism Stimulates pituitary to release Growth Hormone (GH) Stimulates hypothalamus to release GnRH, th…

Continue reading

Related articles